TraceLink is relocating its European headquarters to a larger, newly renovated office space in Uxbridge, UK. The move will accommodate the company’s increase in EU staff growth for 2017.

To help the life sciences industry meet global regulatory deadlines for pharmaceutical track and trace and accommodate its explosive 658% growth in EMEA new sales bookings for Q1 2017, the company is expanding its overall European team by hiring 55 new EU-based employees in sales, services, marketing and administration during 2017.

As part of its recruitment drive, the company has added two regional EU sales leaders, deepening its pan-European presence to develop localized TraceLink teams in specific regions. Leading the DACH (Germany, Austria and Switzerland) region as TraceLink vice president, sales, Manfred Voglmaier, a native resident of Germany, brings over 25 years of industry experience in technology and life sciences, and comes from Systech International as the former senior director of EMEA sales. Heading up Southern Europe, Renaud Delcroix has joined TraceLink as vice president, sales for the region, bringing strong expertise in cultivating international business development teams across industry verticals.

“By 2020, over 80% of the world’s prescription drugs will be covered by track and trace laws; a challenge that involves massive amounts of data and a complex web of supply chain partners. Expanding our presence in Europe is a natural step due to the urgent demand we’ve seen from the region for our proven solution in meeting EU Falsified Medicines Directive (FMD) requirements,” said Shabbir Dahod, president and chief executive officer, TraceLink. “As part of our $70 million investment in 2017 into the pharmaceutical track and trace industry, we are building localized support and services for our customers who have mission-critical operations across 24 countries to best accommodate our rapid-growing global customer base.”